Henry Wolfe, PhD
Board Member
Board Member
Dr. Wolfe earned his PhD in Molecular Pharmacology and Structural Biology in 2006 under Professor Scott Waldman while working full-time over a ten year period. He has worked for 43 years in the biotech/pharma industry and was amongst the first 3 employees in three biotechs and amongst the last in two others. His work has focused on both biology (pharm/tox) and chemistry (discovery & manufacturing) in the development of gene therapies, peptides, biologics and small molecules with FDA approvals for five drugs.